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ABSTRACT 
Recent research has shown there can be detrimental neurological effects of short- and long-term 
exposure to contact sports. In the present study, metabolomic profiling was combined with 
inflammatory miRNA quantification, computational behavior with virtual reality (VR) testing of 
motor control, and head collision event monitoring to explore trans-omic and collision effects on 
human behavior across a season of players on a collegiate American football team. We integrated 
permutation-based statistics with mediation analyses to test complex, directional relationships 
between miRNAs, metabolites, and VR task performance. Fourteen significant mediations 
(metabolite = mediator; miRNA = independent variable; VR score = dependent variable) were 
discovered at preseason (N=6) and across season (N=8) with Sobel p-values ≤ 0.05 and with total 
effects at or exceeding 50%. The majority of mediation findings involved long to medium chain 
fatty acids (2-HG, 8-HOA, UND, sebacate, suberate, and heptanoate). In parallel, TCA metabolites 
were found to be significantly decreased at postseason relative to preseason. HAEs were associated 
with metabolomic measures and miRNA levels across-season. Together, these observations 
suggest a state of chronic HAE-induced neuroinflammation (as evidence by elevated miRNAs) 
and mitochondrial dysfunction (as observed by abnormal FAs and TCA metabolites) that together 
produce subtle changes in neurological function (as observed by impaired motor control behavior). 
These findings point to a shift in mitochondrial metabolism, away from mitochondria function, 
consistent with other illnesses classified as mitochondrial disorders, suggesting a plausible 
mechanism underlying HAEs in contact sports and potential avenue for treatment intervention.  
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INTRODUCTION  
Sports-related concussion remains one of the most common causes of  traumatic brain 
injuries (TBIs), with approximately 1.6-3.8 million occurrences annually [1, 2]. Despite the high 
incidence of concussive injuries in contact sports, the molecular mechanisms of these injuries are 
not well understood, making development of targeted pharmaceutical interventions challenging. 
Additionally, subconcussive injuries (i.e., head impacts yielding minimal diagnosable cognitive or 
behavioral deficits) have also been linked with significant neurophysiological and biochemical 
changes in youth, collegiate, and professional football athletes [3–7]. Due to the lack of observable 
subconcussive-related symptoms, research has sought to identify biomarkers based on advanced 
imaging and omics (e.g., transcriptomics, proteomics) [7–15].  
Previous research by Papa and colleagues, and Bhomia and colleagues, elucidated a panel 
of potential miRNA biomarkers of football-related injury (miR-20a, miR-505, miR-92a, miR-195, 
miR-93p, miR-30d, miR-486, miR-3623p, and miR-151-5p) [16, 17]. This set of miRNAs was not 
only elevated at the end of the football season but was also found to be elevated prior to the season 
when compared to non-athletes reporting to the emergency room with potential concussion [16]. 
Findings from these studies support an inflammatory hypothesis, although we still know little 
about the molecular targets of these miRNAs. Inflammation is energy intensive, suggesting there 
may be alterations in metabolism and energy-related metabolites concurrent with miRNA 
increases. Indeed, MRS studies support this hypothesis [7, 18–21]. Furthermore, metabolomics 
appear to be important in the context of the diffuse axonal injury (DAI) model of mild TBI (mTBI), 
which models how shock-waves affect axons and their structure, which would suggest there may 
be significant effects on a broad array of fatty acids (FAs) involved with axonal function.  
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 Metabolomics allows investigation of metabolic fluctuations following an experimental or 
observational perturbation, such as a season of contact sports participation. A number of molecular 
pathways have been studied in animal models and have been observed to be altered by head 
impacts [22–29]. Across animal and human studies of head impacts, mitochondrial dysfunction 
has been consistently observed [30–36]. Dubbed the powerhouse of the cell, mitochondria are 
critically important for energy production and cellular respiration [37, 38]. Damage to these 
organelles can thus result in serious cellular, and potentially systems-level, dysfunction. 
  One major role of the mitochondria is the oxidation of fatty acids into functional 
metabolites that can then fuel the TCA cycle and downstream energy production [39–41]. Long 
and medium chain fatty acids are first processed in peroxisomes, small organelles that oxidize fatty 
acids via alpha, omega, and beta oxidation [42–44]. Omega oxidation replaces the methyl terminus 
with a hydroxy group (now referred to as a monohydroxy fatty acid) which is then further oxidized 
into a carboxy group (dicarboxylic fatty acid). Once in dicarboxylic form, the fatty acid can then 
be further processed via beta oxidation in both the peroxisome and mitochondria [45, 46]. 
Depending on the length and processing location of the fatty acid, different sets of enzymes are 
utilized to metabolize it into a smaller, functional metabolite – acetyl-CoA. Acetyl-CoA then enters 
the TCA cycle to produce energy (GTP) and energy-storing (NADH and FADH2) metabolites [47]. 
NADH and FADH2 are then used in the electron transport chain to ultimately produce large 
amounts of ATP – the most fundamental source of energy. However, if mitochondrial damage 
occurs from repeated head acceleration events (HAEs) – either associated with direct impacts or 
whiplash motions resulting from collisions elsewhere on the body – metabolites involved in fatty 
acid oxidation (e.g. sebacate) and the TCA cycle (e.g. citrate) may be altered. Additionally, 
mitochondrial distress can result in oxidative stress and increased reactive oxygen species 
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production [48–51]. Therefore, finding a set of metabolites to highlight potential mitochondrial 
dysfunction, while also showing relationships to neurological function/dysfunction and 
neuroinflammatory miRNAs, is a promising and novel biomarker. 
 While the discovery of blood biomarkers is the ultimate clinical goal, it is first necessary 
to establish if biomarkers have relationships with neurological function or dysfunction. Numerous 
studies have attempted to uncover behavioral changes in contact sport athletes, but many tests are 
insensitive to subtle changes in behavior [52–56]. Alexander Luria observed a set of behavioral 
abnormalities in individuals with mTBI that can imply a non-obvious alteration in biology [57–
60]. These observations led to development of computational behavior tasks using virtual reality 
technology that can quantify abnormalities in motor control and are sensitive to motor control 
changes following TBI that may be missed in clinical examination [61–65].  
This study specifically evaluated the hypothesis that an integrated system of omic 
measures, from the transcriptome (miRNA) and metabolome (individualized biochemistry), would 
form three-way associations with computational behavior measures prior to the season (preseason) 
or across the season (i.e., pre- vs. postseason) for a collegiate football team. We predicted these 
trans-omic and behavioral measures would show mediation relationships that were consistent (i.e., 
highly specific) in terms of the category of independent variable (IV), mediator variable (M), and 
dependent variable (DV), and that computational behavior measures would always be the DV. 
Given the large number of associations needing testing for this mediation analysis, we integrated 
permutation-based statistics with mediation analyses in a novel framework to address the issue of 
multiple comparisons. For behavioral tasks, we focused on motor control and spatial memory that 
were described by Luria as being abnormal without obvious head trauma [58]. For miRNA, we 
focused on a panel of miRNAs that had previously been shown to be abnormal relative to 
 6 
emergency room controls in the pre-season, and across-season for football players, and that were 
known to be involved in the control of inflammation [16]. To restrict the number of biochemical 
compounds identified with metabolomics, we focused only on metabolomic measures that were 
significantly different after correction for multiple comparisons across the season, and were (i) 
fatty acids and/or compounds involved with energy metabolism, (ii) compounds involved with 
stress/inflammatory responses, or (iii) exogenous compounds related to consumption. The focus 
of this trans-omics study was to determine if any metabolic pathway and its compounds was 
consistently observed in the majority of mediation relationships to be involved with abnormalities 
in inflammatory miRNAs and Luria-based behaviors. If such a pathway were found, it would 
present a potential unifying construct for head impact/concussion research and clinical 
intervention.  
 Following this approach, we identified a consistent abnormality in fatty acid compounds 
related to mitochondrial β-oxidation and downstream abnormalities in TCA metabolites. 
Alterations in four of the six metabolomic compounds were consistent with a dysfunction in β-
oxidation and showed mediation relationships linking abnormalities in inflammatory miRNAs to 
abnormalities in Luria behaviors. A fifth compound observed in these mediation relationships (i.e., 
2-hydroxyglutarate (2-HG)) was a known oncometabolite that has been implicated in altering the 
balance of oxidative metabolism with mitochondria in cancer cells. The sixth compound (i.e., 
adenosine) represents a fundamental ATP component. The majority of these metabolomic 
compounds were associated with head acceleration events (HAEs). Altogether, these trans-omic 
findings connecting two types of omic measures with quantitative variables from a well-controlled 
and ethologically grounded behavior, supports a hypothesis that repetitive HAEs produce a 
syndrome of abnormal mitochondrial metabolism. 
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MATERIALS/METHODS 
Subjects and data collection 
Twenty-four male collegiate American football players (mean age = 21 ±	2 years) were 
recruited for this study. Written informed consent was obtained from each subject in accordance 
with the Penn State University Institutional Review Board. Demographic information was 
obtained from each subject and confirmed by a team physician: age, years of play experience 
(YoE), player position, and history of diagnosed concussion (HoC; reported as the number of 
previous concussions). Blood samples were taken prior to any contact practices (preseason) and 
within one week of the last game (postseason). None of the subjects had a diagnosed concussion 
in the nine months preceding preseason data collection. Blood samples were prepared and sent out 
for miRNA quantification and metabolomic analysis. Due to missing miRNA data, the number of 
subjects decreased from 24 to between 21-23 depending on the miRNA of interest. Concurrent 
with blood collection, players also underwent virtual reality (VR) testing.  
 
Serum extraction 
Five mL of blood were collected from each subject at pre- and postseason. Samples were 
placed in a serum separator tube, allowed to clot at room temperature, and then centrifuged. Serum 
was extracted from each tube and pipetted into bar-coded aliquot tubes. Serum samples were stored 
at -70°C until they were transported to 1) a central laboratory for blinded miRNA batch analysis 
and 2) Metabolon (Morrisville, NC, USA) for blinded metabolite analysis.  
 
Virtual reality testing 
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Virtual reality testing was conducted using a 3D TV system, head-mounted accelerometer, 
and interactive joystick device from Head Rehab LLC (Chicago, IL, USA). There were three 
separate VR tests: 1) balance (Bal), 2) whole-body reaction time (RT), and 3) spatial memory 
(SM). The scores from each test were combined to produce a comprehensive score (Comp). These 
tests were based off initial findings from Dr. Alexander Luria and have been validated to detect 
functional abnormalities following mild traumatic brain injury [57–59, 65, 66]. The Bal module 
tested subjects’ abilities to maintain posture with a changing virtual environment. Subjects were 
instructed to hold a tandem Romberg position on a pressure plate for each trial [67]. The first trial 
collected baseline pressure data and the subsequent six trials tested performance. The virtual 
environment shifted in a different direction for each performance trial and deviances from baseline 
pressure points were reported. The RT module tested the time it took for subjects to adjust their 
posture in the direction of an altered virtual environment. Subjects stood shoulder-width apart with 
their hands on their hips and were instructed to move their hips in the direction of the virtual 
environment. Results were recorded using the pressure plate and reported as latency to shift the 
body. The SM module tested a subject’s ability to recall a virtual pathway by first viewing and 
then recalling and navigating the pathway with the joystick; results were reported as the accuracy 
of correct responses relative to errors. More detailed descriptions of the tasks have been previously 
reported [68]. VR tests were conducted concurrent with blood sampling.   
 
miRNA quantification  
Serum samples collected at pre- and postseason were used to isolate and quantify levels of 
RNA. 100 𝜇L of serum was aliquoted, and RNA was isolated using a serum/plasma isolation kit 
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(Qiagen Inc., Venlo, Netherlands) as per the manufacturer’s protocol. RNA was eluted in 20	𝜇L 
of DNAse/RNAse-free water and stored at -80°C until further use.  
Droplet digital PCR (ddPCR; Bio-Rad Inc., Hercules, CA, USA) was used to quantify 
absolute levels of nine miRNA (miR-20a, miR-505, miR-3623p, miR-30d, miR-92a, miR-486, 
miR-195, miR-93p, miR-151-5p) [16]. Prior to ddPCR analysis, RNA was checked for quality 
using a bioanalyzer assay with a small RNA assay. After quality confirmation, 10 ng of RNA was 
reverse transcribed using specific miRNA TaqMan assays as per the manufacturer’s protocol 
(Thermo Fisher Scientific Inc., Waltham, MA, USA). Protocol details can be found in [16]. The 
final PCR product was analyzed using a droplet reader (Bio-Rad Inc., Hercules, CA, USA). Total 
positive and negative droplets were quantified, and from this, the concentration of miRNA/𝜇L of 
the PCR reaction was reported. All reactions were performed in duplicate. 
 
Metabolomic analysis  
The remaining serum was sent to Metabolon (Morrisville, NC, USA) for metabolomic 
quantification. Upon arrival, samples were assigned a unique identifier via an automated 
laboratory system and stored at -80°C. Samples were prepared for subsequent analyses using an 
automated MicroLab STAR® system (Hamilton Company, Reno, NV, USA). Proteins were 
precipitated out of each sample using methanol and a shaker (Glen Mills GenoGrinder 2000), and 
then centrifuged. The resulting extract was then divided into five fractions for various analyses: 1) 
two fractions for analysis by two separate reverse phase (RP)/UPLC-MS/MS methods with 
positive ion mode electrospray ionization (ESI), 2) one for analysis by RP/UPLC-MS/MS with 
negative ion mode ESI, 3) one for analysis by HILIC/UPLC-MS/MS with negative ion mode ESI, 
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and 4) one reserved for backup. To remove organic solvent, samples were briefly placed on a 
TurboVap® (Zymark); samples were then stored under nitrogen overnight prior to analyses.  
 Serum metabolites were quantified using Ultrahigh Performance Liquid Chromatography-
Tandem Mass Spectroscopy (UPLC-MS/MS). All methods utilized a Waters ACQUITY UPLC 
and a Thermo Scientific Q-Exactive high resolution/accurate mass spectrometer interfaced with a 
heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 
mass resolution. The sample extract was dried and reconstituted in solvents compatible to each of 
the listed analyses. Each reconstitution solvent contained a series of standards at fixed 
concentrations to ensure injection and chromatographic consistency. One aliquot was analyzed 
using acidic positive ion conditions, chromatographically optimized for more hydrophilic 
compounds. In this method, the extract was gradient eluted from a C18 column (Waters UPLC 
BEH C18-2.1x100 mm, 1.7 µm) using water and methanol, containing 0.05% perfluoropentanoic 
acid (PFPA) and 0.1% formic acid (FA). Another aliquot was also analyzed using acidic positive 
ion conditions; however, it was chromatographically optimized for more hydrophobic compounds. 
In this method, the extract was gradient eluted from the same afore mentioned C18 column using 
methanol, acetonitrile, water, 0.05% PFPA and 0.01% FA and was operated at an overall higher 
organic content. Another aliquot was analyzed using basic negative ion optimized conditions using 
a separate dedicated C18 column. The basic extracts were gradient eluted from the column using 
methanol and water, however with 6.5mM Ammonium Bicarbonate at pH 8. The fourth aliquot 
was analyzed via negative ionization following elution from a HILIC column (Waters UPLC BEH 
Amide 2.1x150 mm, 1.7 µm) using a gradient consisting of water and acetonitrile with 10mM 
Ammonium Formate, pH 10.8. The MS analysis alternated between MS and data-dependent MSn 
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scans using dynamic exclusion. The scan range varied slighted between methods but covered 70-
1000 m/z.   
 Peak analysis was conducted using a bioinformatics system which consisted of four major 
components: 1) the Laboratory Information Management System (LIMS - a system used to 
automate sample accession and preparation, instrumental analysis and reporting, and data 
analysis), 2) the data extraction and peak-identification software, 3) data processing tools for 
quality control and compound identification, and 4) a collection of information interpretation and 
visualization tools.  
Raw data were extracted, peak-identified, and QC processed using Metabolon’s hardware 
and software. Compounds were identified by comparison to library entries of purified standards. 
Biochemical identifications were based on three criteria: 1) retention index (RI) within a narrow 
RI window of the proposed identification, 2) accurate mass match to the library (+/- 10 ppm), and 
3) the MS/MS forward and reverse scores between the experimental data and authentic standards. 
The MS/MS scores were based on a comparison of the ions present in the experimental spectrum 
to the ions present in the library spectrum. While there may have be similarities between these 
molecules based on one of these factors, the use of all three data points was utilized to distinguish 
and differentiate more than 3,300 registered biochemicals.  
Peaks were quantified using area-under-the-curve. A data normalization step was 
performed to correct variation resulting from instrument inter-day tuning differences (i.e. variation 
between pre and postseason analyses). Specifically, each compound was corrected in run-day 
blocks by registering the medians to equal one (1.00) and normalizing each data point 
proportionately. Data were then log-transformed. Of the 3,300+ potential biochemicals, 968 
metabolites were analyzed at pre and postseason. Of these, 161 showed significant, FDR-
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corrected, increases or decreases between the pre and postseason (q-value < 0.05). Of those 161 
metabolites, 40 were selected based on the following criteria: 1) they appeared in the random forest 
plot (20 of the 40 studied here) (Figure 1) and 2) they were in biochemical pathways which have 
been implicated to change following head impact events [69–73]. Based on these criteria, six 
macromolecule categories were defined: lipids (19/40), energy-related metabolites (5/40), 
xenobiotics (10/40), amino acids (3/40), carbohydrates (2/40), and nucleotides (1/40) (Table 1). 
All 40 metabolites listed in Table 1 were used in all subsequent analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Random forest plot of metabolite importance. The mean decrease accuracy (MDA) is a measure 
of model performance when a particular metabolite was excluded from the analysis. As MDA increased, 
the more important that metabolite was to distinguish pre- versus post-season data. The metabolite with the 
highest MDA, and therefore, highest predictive power, was 2-hydroxyglutarate, a fatty acid. The majority 
of metabolites in the plot were lipids (55%). 
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Table 1: Metabolite changes across season. Metabolite levels between pre- and post-season were assessed 
using the Wilcoxon signed-rank test, a nonparametric t-test for paired samples. Metabolites were grouped 
by super pathway and FDR corrected by the number of variables in each group (e.g. 19 lipid metabolites). 
Metabolites with significant q-values were reported. Negative z-scores indicate an increase from pre- to 
post-season and positive z-scores indicate a decrease from pre- to post-season. * indicates metabolites that 
also appeared in the random forest plot. 
 
 
Statistical analysis 
All statistical analyses were performed in STATA (College Station, TX, USA) apart from 
the random forest analysis which was performed by Metabolon.  
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Random Forest analysis: Random forest is an unsupervised classification technique based on an 
ensemble of decision trees; here, it was used to assess the importance ranking of biochemicals (i.e., 
how well can a given metabolite be used to distinguish preseason from postseason) [74]. For a 
given decision tree, a random subset of the data, with identifying true class information, was 
selected to build the tree (“bootstrap sample” or “training set”), and then the remaining data, the 
“out-of-bag” (OOB) variables, were passed down the tree to obtain a class prediction for each 
sample. This process was repeated thousands of times to produce the forest. The final classification 
of each sample was determined by computing the class prediction frequency for the OOB variables 
over the whole forest. When the full forest was grown, the class predictions were compared to the 
true classes, generating the “OOB error rate” as a measure of prediction accuracy. Thus, the 
prediction accuracy was an unbiased estimate of how well a sample class was predicted in a new 
data set. To determine which biochemicals made the largest contribution to the classification, a 
variable importance measure, Mean Decrease Accuracy (MDA), was computed. MDA was 
determined by randomly permuting a variable, running the observed values through the trees, and 
then reassessing the prediction accuracy. If a variable was not important, the procedure produced 
little change in the accuracy of the class prediction (permuting random noise gave random noise). 
By contrast, if a variable was important to the classification, the prediction accuracy dropped; this 
was recorded as the MDA. 
 
Wilcoxon signed-rank test for across-season miRNA, metabolite, and VR score analysis: Data were 
first tested for normality and equal variances using the Shapiro-Wilks test and Bartlett’s test, 
respectively. Because 1) data were not normally distributed (Shapiro-Wilks test; p ≥ 0.05) and/or 
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data did not have equal variances (Bartlett’s test; p ≥	0.05) and 2) data were paired by subject 
across-season, a Wilcoxon signed-rank test was utilized to assess across-season changes. Changes 
were analyzed at a significance level of 0.05. If p-value < 0.05, metabolites were then grouped 
based on super pathway and FDR-corrected using the Benjamini-Hochberg method for multiple 
comparisons (Table 1). Changes were considered significant if q-value ≤ 0.05.  
 
Linear regression analyses: Linear regressions were conducted to assess significant interactions 
between VR scores and miRNAs, miRNAs and metabolites, and VR scores and metabolites, where 
VR score (i.e., behavior) was always the dependent variable (Y). When regressing miRNA and 
metabolite, metabolite was the designated as the dependent variable; this decision was based on 
previous findings where miRNA levels were elevated in this cohort at preseason when compared 
to controls [16]. After each initial regression analysis, Cook’s distance was calculated to reveal 
outliers which drastically influenced the regression (i.e., large shift in β) [75, 76]. Outliers were 
removed if Cook’s distance > 4/n and regressions were then re-run [77]. Regressions were 
considered significant if p-value < 0.05 and standardized beta coefficients (Std. β) and adjusted R2 
values (R!"#.% ) were also reported. 
 
Permutation-based mediation analysis: Based on results from the linear regression analyses, data 
were prepared for mediation analysis by first assessing three-way associations. To be included in 
mediation analysis, all paths must have met significance (p-value < 0.05) to form a three-way 
association. Paths were as follows: A) miRNA (X) à metabolite (Y), B) metabolite (Y) à VR 
score (Z), and C) miRNA (X) à VR score (Z). Cook’s outliers were removed across all regressions 
to achieve the same set of subjects, and regressions were re-run with common subjects. Mediation 
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seeks to clarify the causal relationship between the independent variable (X) and dependent 
variable (Y) with the inclusion of a third variable mediator (M). The mediation model proposes 
that instead of a direct causal relationship between X and Y, the X influences M which then 
influences the Y. Beta coefficients (β) and standard error (se) terms from the following linear 
regression equations are used to calculate the Sobel p-value and mediation effect percentage (Teff): 
 𝑆𝑡𝑒𝑝	1	(𝑃𝑎𝑡ℎ	𝐴):𝑀 = 𝛽& + 	𝛽'((𝑋) + 𝜖( 
 𝑆𝑡𝑒𝑝	2	(𝑃𝑎𝑡ℎ	𝐵): 𝑌 = 𝛽& + 	𝛽')(𝑀) + 𝜖) 
   																		𝑆𝑡𝑒𝑝	3	(𝑃𝑎𝑡ℎ	𝐶, 	𝑚𝑜𝑑𝑒𝑙	1): 	𝑌 = 	𝛽& + 	𝛽','+(𝑋) + 𝜖'+  
 																																															𝑆𝑡𝑒𝑝	4	(𝑃𝑎𝑡ℎ	𝐶, 	𝑚𝑜𝑑𝑒𝑙	2): 	𝑌 = 	𝛽& + 	𝛽',%+(𝑋) + 	𝛽%,%+(𝑀) + 𝜖%+	 
 
Sobel’s test was then used to test if 𝛽',%+  was significantly lower than 𝛽','+  using the following 
equation: 
(3)	𝑆𝑜𝑏𝑒𝑙	𝑧 − 𝑠𝑐𝑜𝑟𝑒 = 	 (𝛽','+ − 𝛽',%+)LMN𝛽%,%+O%(𝜖'()%P + [(𝛽'()%(𝜖%+)%]	 
 
Using a standard 2-tail z-score table, the Sobel p-value was determined from Sobel z-score. 
Mediation effect percentage (Teff) was calculated using the following equation: 
(4)	𝑇-.. = 100 ∗ N𝛽'( ∗ 𝛽%,%+ON𝛽'( ∗ 𝛽%,%+O + V𝛽','+ − N𝛽'( ∗ 𝛽%,%+OW 
 
 
In order to control for the occurrence of false positives due to multiple hypotheses testing, 
permutation-based mediation analysis was utilized. Permutation tests re-sample observations from 
the original data multiple times to build empirical estimates of the null distribution for the test 
statistic being studied [78, 79]. Permutation-based tests are especially well-suited for studies with 
 17 
small sample sizes as they estimate the statistical significance directly from the data being analyzed 
rather than making assumptions about the underlying distribution. First, the test statistic is obtained 
from the original data set, then the data is randomly permuted multiple (S) times and the test 
statistic is computed on each permutated data set. The statistical significance is computed by 
counting (K) the number of times the statistic value obtained in the original data set was more 
extreme than the statistic value obtained from the permuted data sets, and dividing that value by 
the number of random permutations (K/S) [78]. 
  Directed mediation analysis was performed with VR score always acting as the dependent 
variable (DV/Y); this a priori hypothesis has been observed in previous studies [80]. Secondly, 
for the hypothesis-directed mediation analyses, miRNA was always the independent variable 
(IV/X) and metabolite was always the mediator (M): 𝑉𝑅	𝑠𝑐𝑜𝑟𝑒 = 	𝛽& + 	𝛽','+(𝑚𝑖𝑅𝑁𝐴) + 𝜖'+  
 𝑉𝑅	𝑠𝑐𝑜𝑟𝑒 = 	𝛽& + 	𝛽',%+(𝑚𝑖𝑅𝑁𝐴) + 	𝛽%,%+(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒) + 𝜖%+	 
 
The selection for IV was based off work by Papa et al. (2019) where miRNA levels were observed 
to be elevated in collegiate football athletes, compared to controls, at both pre- and postseason 
[16]. Therefore, metabolites, which can change dynamically, were hypothesized to mediate the 
relationship between elevated miRNAs and VR task performance. For control mediation analyses, 
VR score was DV, miRNA was M, and metabolite was IV: 𝑉𝑅	𝑠𝑐𝑜𝑟𝑒 = 	𝛽& + 	𝛽','+(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒) + 𝜖'+  
 𝑉𝑅	𝑠𝑐𝑜𝑟𝑒 = 	𝛽& + 	𝛽',%+(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒) + 	𝛽%,%+(𝑚𝑖𝑅𝑁𝐴) + 𝜖%+	 
 
The measurement matrices 𝑋/ , 𝑌/ , 𝑀/	defined below schematize the variables used, miRNAs, VR 
scores, and metabolites respectively. 
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  𝑋/ = \𝑥/,','⋮𝑥/,',0 … 𝑥/,1,'⋮𝑥/,1,0`, 𝑌/ = \𝑦/,','⋮𝑦/,',0 … 𝑦/,2,'⋮𝑦/,2,0`, 𝑀/ = \𝑚/,','⋮𝑚/,',0 …𝑚/,3,'⋮𝑚/,3,0` 
 
where P is the total number of variables in matrix 𝑋/ (i.e. the total number of miRNAs) Q and R 
are the total number of variables for matrices 𝑌/	and	𝑀/	respectively. N denotes the number of 
participants and the matrices were measured at two time points with 𝑡 = 1 representing pre- and 𝑡 = 2 representing postseason measurements.  
Across-season measures for miRNAs, VR scores, and metabolites were calculated as  
 ∆𝑋 = 	𝑋% − 𝑋'	∆𝑌 = 	𝑌% − 𝑌' ∆𝑀 = 	𝑀% −𝑀' 
 
For this study, permutation-based mediation analysis was performed for all three-way 
associations following the steps listed below: 
1. Mediation analysis was performed by assigning the original data variables ∆𝒙𝒊, ∆𝒚𝒋, ∆𝒎𝒌 
as independent, dependent, and mediator variables, respectively, to obtain reference the 
Sobel z-score (𝑧&). Only variables that formed three-way associations were considered. 
(For pre-season analysis, 𝒙𝟏,𝒊, 𝒚𝟏,𝒋,𝒎𝟏,𝒌 were used to obtain the reference Sobel z-score 
(𝑧&)). 
2. Data permutation: values were randomly selected from 𝒙𝟏,𝒊 and 𝒙𝟐,𝒊 to assign to 𝒙𝟏,𝒊9  and 𝒙𝟐,𝒊9 . (For pre-season analysis, values from 𝒙𝟏,𝒊 were shuffled to get 𝒙𝟏,𝒊9 .) 
3. Across-season measures were computed from the permuted dataset ∆𝒙𝒊9 = 𝒙𝟐,𝒊9 − 𝒙𝟏,𝒊9 .. 
(Note that for pre-season analysis, the difference was not computed.) 
4. Similarly, ∆𝒚𝒋9 and ∆𝒎𝒌9  were computed. (For pre-season analysis, 𝒚𝟏,𝒋9 ,𝒎𝟏,𝒌9  were 
computed by randomly shuffling values in 𝒚𝟏,𝒋,𝒎𝟏,𝒌.) 
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5. Mediation analysis was performed on the permuted dataset ∆𝒙𝒊9, ∆𝒚𝒋9, ∆𝒎𝒌9  and the test 
statistics (𝑧:9) was obtained. (For pre-season analysis, mediation was performed on the 
permuted data set 𝒙𝟏,𝒊9 , 𝒚𝟏,𝒋9 , 𝒎𝟏,𝒌9  and 𝑧:9  was obtained.) 
6. The counter variable 𝐾 was incremented by one if the absolute value of 𝑧& was greater than 
the absolute value of  𝑧:9 . 
7. Steps 2-6 were repeated: 𝑠 = 1,2, 	⋯ , 𝑆 times. 
8. Permutation-based p-value (𝑝;<=>?@>AB) was calculated as the proportion of 𝑧:9  values that were 
as extreme or more extreme than 𝑧&	(i.e. 𝐾/𝑆	). 
 
Hypothesis-directed mediation results were considered significant if 𝑝CDE-FG-HI < 0.05, Teff was > 50%, 
and Teff for the control mediation was < 30%.  
 
Head acceleration event (HAE) monitoring 
HAEs were monitored at all contact practice sessions (max = 53) using the BodiTrak sensor 
system from The Head Health Network  [81]. Sensors were mounted in each active player’s helmet 
prior to contact practice (no games were monitored). Sensor outputs included peak translational 
acceleration (PTA; G-units) and impact location. HAEs were quantified as 1) cumulative hits 
exceeding 25G and 80G (cHAE25G and cHAE80G; Eq. 1) and 2) cumulative hits exceeding 25G 
and 80G normalized to the total number of sessions per player (aHAE25G and aHAE80G; Eq.2). The 
G-unit thresholds (Th) were selected based on previous reports of impacts related to brain health 
and injury [82, 83].  
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(1)	𝑐𝐻𝐴𝐸JK,L =	l𝑢N𝑃𝑇𝐴M,L − 𝑇ℎO	0MN'  
 𝑤ℎ𝑒𝑟𝑒	𝑢(𝑥) = o1	𝑖𝑓	𝑥 > 00	𝑖𝑓	𝑥	 ≤ 0 
 (2)	𝑎𝐻𝐴𝐸JK,L = 𝑐𝐻𝐴𝐸JK,L𝑠𝑒𝑠𝑠𝑖𝑜𝑛𝑠L 	 
 
RESULTS  
Random forest plot revealed biochemically important metabolites 
Of the 1300+ metabolites analyzed, 20 metabolites with the highest predictive power to 
distinguish between pre- and postseason (i.e. importance) were plotted (Figure 1). Of these 
metabolites 11/20 (55%) were lipids, 3/20 (15%) were amino acids, 2/20 (10%) were 
carbohydrates, 3/20 (15%) were xenobiotics, and 1/20 (5%) was an amino acid. The metabolite 
with the highest predictive power was 2-hydroxyglutarate (2-HG), followed by three other lipids. 
All 20 metabolites from the random forest plot were included in additional analyses. 
 
Wilcoxon signed-rank analyses revealed significant across-season metabolite changes  
Wilcoxon signed-rank tests were conducted to determine which miRNA, metabolites, and 
VR scores significantly fluctuated between pre- and postseason. There were no significant (p-value 
> 0.05) changes in miRNA levels and VR scores between pre- and postseason. Of the 968 
metabolites analyzed, 259 significantly increased or decreased (p-value ≤ 0.05) between pre- and 
postseason. Following FDR correction, 161 significantly increased or decreased (q-value ≤ 0.05). 
Of those 161 metabolites, 40 were selected based on the criteria described in Metabolomic analysis 
(Figure 1). Of the 40 metabolites, 26 significantly increased (negative z-score) and 14 decreased 
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(negative z-score) (Table 1). 48% of the metabolites were lipids and 52% fell in another category 
(12.5% energy-related, 25% xanthine, 7.5% amino acid, 5% carbohydrate, and 2.5% nucleic acid). 
Of the lipids, 74% were fatty acids (FAs) and 26% were other lipid types. Overall, 35% of the 
metabolites were FAs and 65% fell in another category. Of the FAs, 79% significantly increased 
from pre- to postseason. Additionally, all TCA-related metabolites (𝛼-ketoglutarate, citrate, 
aconitate, and fumarate) decreased from pre- to postseason and all of the xanthine metabolites (e.g. 
paraxanthine) increased.  
 
Summary of preseason and across-season interactions between miRNAs, metabolites, and 
VR scores  
Linear regressions were conducted to assess interactions between four VR scores (Bal, RT, 
SM, and Comp), nine miRNAs (miR-20a, miR-505, miR-3623p, miR-30d, miR-92a, miR-486, 
miR-92a, miR-93p, and miR-151-5p), five HAE metrics (sessions, cHAE25G, aHAE25G, cHAE80G, 
and aHAE80G), and 40 metabolites (Supplemental Table 1). At preseason, there were nine 
significant interactions between VR scores and miRNAs, 15 between VR scores and metabolites, 
and 36 between miRNAs and metabolites (p ≤ 0.05 following Cook’s outlier removal) (Figure 2). 
Across-season (postseason−preseason), there were 12 significant interactions between VR scores 
and miRNAs, 20 between VR scores and metabolites, and 31 between miRNAs and metabolites 
(p ≤ 0.05 following Cook’s outlier removal) (Figure 3). In general, both pre- and across-season 
analyses revealed negative relationships between VR scores and miRNAs and positive 
relationships between VR scores and metabolites (exceptions: cortoloneglucuronide, 
corticosterone, adenosine, and tridecenedioate). Relationships between miRNAs and metabolites 
varied with the majority being negative (79%).  
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Figure 2: Preseason linear regression results. Cook’s outliers were removed prior to regression analysis 
and the number of outliers removed in each regression is listed as the ratio of outliers to the total n. Adjusted 
R2 (R!"#.% ) is reported for each regression and relays the amount of variance in Y that can be explained by 
X. p-Values are reported at a significance level of 0.05. (A) Significant interactions between VR scores and 
miRNA levels. (B) Significant interactions between VR scores and metabolite levels. (C) Significant 
interactions between miRNA and metabolite levels.   
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Figure 3: Across-season linear regression results. Variables are expressed as the difference between 
postseason and preseason values (post-pre = ∆). Cook’s outliers were removed prior to regression analysis 
and the number of outliers removed in each regression is listed as the ratio of outliers to the total n. Adjusted 
R2 (R!"#.% ) is reported for each regression and relays the amount of variance in Y that can be explained by 
X. p-Values are reported at a significance level of 0.05. (A) Significant interactions between ∆VR scores 
and ∆miRNA levels (IV). (B) Significant interactions between ∆VR scores and ∆metabolite levels. (C) 
Significant interactions between ∆miRNA and ∆metabolite levels.   
 
 
Three-way associations between miRNAs, metabolites, and VR scores at preseason and 
across-season 
As a prerequisite for mediation analysis, only regressions which formed three-way 
associations were considered (e.g. significant interactions between X à Y, Y à Z, and X à Z; 
see below). 
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In total, there were 50 potential three-way associations – 18 at preseason and 32 across-
season. The majority of three-way associations included Comp behavior (70%) and 88% of three-
way associations included a FA metabolomic measure. Following Cook’s outlier removal across 
all regressions, 11/18 preseason three-way associations met significance (p-value < 0.05) for all 
pathways (A, B, and C). Across-season, 14/32 associations met a p-value < 0.05 threshold. Of the 
25 significant three-way associations, 92% included a FA metabolomic measure and 88% included 
Comp behavior. There were six miRNAs involved in pre- and across-season three-way 
associations: miR-20a, miR-505, miR-92a, miR-151-5p, miR-195, and miR-30d (five at preseason 
and five across-season). 
 
Mediation analyses revealed causal mediations at preseason and across-season  
Mediation analyses were performed to assess the causal influence of metabolites on the 
relationship between miRNAs and VR scores and contrasted against a control mediation analyses 
that switched the roles of metabolites and mRNAs. Specifically, the hypothesized mediation was 
directed so miRNA was the independent variable, metabolite was the mediator, and VR score was 
the dependent variable. Of the 18 preseason three-way associations, 11 survived following 
combined removal of Cook’s outliers across all paths (A, B, and C) – ensuring the same set of 
subjects were being analyzed. Mediation analysis revealed six significant preseason mediations 
(Sobel p-value < 0.05, Teff ≥ 50%; Table 2, bolded and italicized rows). Figure 4 depicts each 
significant mediation, including the directionality and significance of each regression interaction. 
Path B 
p < 0.05 
Path C 
p < 0.05 
Path A 
p < 0.05 
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The graphs illustrate the slopes of linear models 1 (IV à DV) versus 2 (IV + M à DV). In each 
case, the slope of model 1 was larger than that of model 2, indicating that the metabolite (M) 
significantly impacted the relationship between the miRNA (IV) and VR score (DV). The 
directionality of the linear regression relationships was common across all preseason mediations 
– negative between miRNA and metabolite, negative between miRNA and VR score, and positive 
between metabolite and VR score. No control mediations met both a significant p-value and a Teff 
greater than 50% when metabolite was the IV, miRNA was the M, and VR score was the DV (p-
value > 0.048, Teff ≤ 30%). 
 
Table 2: Permutation-based preseason mediation results. The a priori hypothesis assumed that miRNA was 
the IV, metabolite was the M, and VR score was the DV. Control mediations were run with metabolite as 
the IV, miRNA as the M, and VR score as the DV. Beta coefficients and standard error terms from Table 1 
were used to calculate permutation-based Sobel p-values (significance level = 0.05) and total effect 
mediated (Teff; expressed as %). Results with permutation-based Sobel p-values (𝑝&'()*+),-) ≥ 0.05 and % ≥ 
50 were considered significant. Of the 11 three-way associations, six showed a significant mediation effect 
(bolded and italicized rows).  
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Figure 4: Significant preseason mediation results. In all analyses, miRNA was the independent variable,  
metabolite was the mediator, and VR score was the dependent variable. Cook’s distance outliers were 
removed prior to analyses, VR terms were reported as standardized values, Adjusted R2 (R!"#.% ) values were 
reported for each regression, and all p-values were reported at a significance level 0.05. (A) There was a 
negative interaction between miR-20a and 2-hydroxyglutarate (2-HG), a positive interaction between 2-
HG and VR composite score (Comp), and a negative interaction between miR-20a and Comp. When 2-HG 
was added to the regression model, the relationship between miR-20a and Comp no longer existed (p-value 
> 0.05); therefore, 2-HG significantly mediated the relationship (Sobel p-value = 0.002, Teff = 52%). The 
graph depicts the change in slope between model 1, which plots the slope term for the interaction between 
miR-20a and Comp, and model 2, which plots the slope term for the interaction between miR-20a and 
Comp when 2-HG was included in the regression model. (B) There was a negative interaction between 
miR-20a and 8-hydroxyoctanoate (8-HOA), a positive interaction between 8-HOA and Comp, and a 
negative interaction between miR-20a and Comp. When 8-HOA was added to the regression model, the 
relationship between miR-20a and Comp no longer existed (p-value > 0.05); therefore, 8-HOA significantly 
mediated the relationship (Sobel p-value = 0.005, Teff = 59%). The graph depicts the change in slope 
between model 1, which plots the slope term for the interaction between miR-20a and Comp, and model 2, 
which plots the slope term for the interaction between miR-20a and Comp when 8-HOA was included in 
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the regression model. (C) There was a significant negative interaction between miR-505 and 2-HG, a 
significant positive interaction between 2-HG and Comp, and a significant negative interaction between 
miR-505 and Comp. When 2-HG was added to the regression model, the relationship between miR-505 
and Comp no longer existed (p-value > 0.05); therefore, 2-HG significantly mediated the relationship (Sobel 
p-value = 0.00006, Teff = 90%). The graph depicts the change in slope between model 1, which plots the 
slope term for the interaction between miR-505 and Comp, and model 2, which plots the slope term for the 
interaction between miR-505 and Comp when 2-HG was included in the regression model. (D) There was 
a negative interaction between miR-92a and 8-HOA, a positive interaction between 8-HOA and Comp, and 
a negative interaction between miR-92a and Comp. When 8-HOA was added to the regression model, the 
relationship between miR-92a and Comp no longer existed (p-value > 0.05); therefore, 8-HOA significantly 
mediated the relationship (Sobel p-value = 0.001, Teff = 78%). The graph depicts the change in slope 
between model 1, which plots the slope term for the interaction between miR-92a and Comp, and model 2, 
which plots the slope term for the interaction between miR-92a and Comp when 8-HOA was included in 
the regression model. (E) There was a negative interaction between miR-151-5p and 8-HOA, a positive 
interaction between 8-HOA and Comp, and a negative interaction between miR-151-5p and Comp. When 
8-HOA was added to the regression model, the relationship between miR-151-5p and Comp no longer 
existed (p-value > 0.05); therefore, 8-HOA significantly mediated the relationship (Sobel p-value = 0.004, 
Teff = 50%). The graph depicts the change in slope between model 1, which plots the slope term for the 
interaction between miR-151-5p and Comp, and model 2, which plots the slope term for the interaction 
between miR-151-5p and Comp when 8-HOA was included in the regression model. (F) There was a 
negative interaction between miR-151-5p and undecanedioate (UND), a positive interaction between UND 
and Bal, and a negative interaction between miR-151-5p and Bal. When UND was added to the regression 
model, the relationship between miR-151-5p and Bal no longer existed (p-value > 0.05); therefore, UND 
significantly mediated the relationship (Sobel p-value = 0.001, Teff = 63%). The graph depicts the change 
in slope between model 1, which plots the slope term for the interaction between miR-151-5p and Bal, and 
model 2, which plots the slope term for the interaction between miR-151-5p and Bal when UND was 
included in the regression model. 
 
Across-season mediation analysis revealed eight mediations meeting our thresholds (Sobel 
p-value < 0.05; Teff > 50%; Table 3, bolded and italicized rows). Figure 5A-H visualizes each 
across-season mediation, including the directionality of each interaction. The plots depict the 
slopes of linear models 1 (IV à DV) versus 2 (IV + M à DV). In each case, the slope of model 
1 was larger than that of model 2. Mediations depicted in Figures 5A-C and 5F-H share the same 
directionality across regressions: negative between miRNA and metabolite, positive between 
metabolite and VR score, and negative between miRNA and VR score. In 5D-E, the interactions 
between miRNA (miR-30d) and metabolite (adenosine), as well as metabolite and VR score 
(Comp), were opposite of those depicted in 5A-C. Only one control mediation met threshold when 
metabolite was the IV, miRNA was the M, and VR score was the DV (p-value = 0.011, Teff = 
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68%); in this case the hypothesized mediation also had a significant Sobel p-value (p-value = 
0.047), indicating a mixed mediation model. 
 
 
 
Table 3: Permutation-based across-season mediation results. The a priori hypothesis assumed that ∆miRNA was the IV, ∆metabolite was the M, and ∆VR score was the DV. Control mediations were run 
with ∆metabolite as the IV, ∆miRNA as the M, and ∆VR score as the DV. Beta coefficients and standard 
error terms from Table 1 were used to calculate permutation-based Sobel p-values (significance level = 
0.05) and total effect mediated (Teff; expressed as %). Results with permutation-based Sobel p-values 
(𝑝&'()*+),-) ≥ 0.05 and % ≥ 50 were considered significant. Of the 14 three-way associations, eight showed a 
significant mediation effect (bolded and italicized rows).  
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Figure 5A-H: Significant 
across-season mediation 
results. In all analyses, ∆miRNA was the independent 
variable, ∆metabolite was the 
mediator, and ∆VR score was 
the dependent variable. Cook’s 
distance outliers were removed 
prior to analyses, ∆VR terms 
were reported as standardized 
values, Adjusted R2 (R!"#.% ) 
values were reported for each 
regression, and all p-values 
were reported at a significance 
level 0.05. (A) There was a 
negative interaction between ∆miR-505 and ∆sebacate, a 
positive interaction between ∆sebacate and ∆Comp, and a 
negative interaction between ∆miR-505 and ∆Comp. When ∆sebacate was added to the regression model, the relationship between ∆miR-505 and ∆Comp no longer existed; therefore, sebacate significantly mediated the relationship (Sobel 
p-value = 0.008, Teff = 50%). The graph depicts the change in slope between model 1, which plots the slope 
term for the interaction between ∆miR-505 and ∆Comp, and model 2, which plots the slope term for the 
interaction between ∆miR-505 and ∆Comp when ∆sebacate was included in the regression model. (B) There 
was a negative interaction between ∆miR-505 and ∆8-hydroxyoctanoate (∆8-HOA), a positive interaction 
between ∆8-HOA and ∆Comp, and a negative interaction between ∆miR-505 and ∆Comp. When ∆8-HOA 
was added to the regression model, the relationship between ∆miR-505 and ∆Comp no longer existed; 
therefore, 8-HOA significantly mediated the relationship (Sobel p-value = 0.007, Teff = 59%). The graph 
depicts the change in slope between model 1, which plots the slope term for the interaction between ∆miR-
505 and ∆Comp, and model 2, which plots the slope term for the interaction between ∆miR-505 and ∆Comp 
when ∆8-HOA was included in the regression model. (C) There was a negative interaction between ∆miR-
195 and ∆heptanoate, a positive interaction between ∆heptanoate and ∆Comp, and a negative interaction 
between ∆miR-195 and ∆Comp. When ∆heptanoate was added to the regression model, the relationship 
between ∆miR-195 and ∆Comp no longer existed; therefore, heptanoate significantly mediated the 
relationship (Sobel p-value = 0.029, Teff = 50%). The graph depicts the change in slope between model 1, 
which plots the slope term for the interaction between ∆miR-195 and ∆Comp, and model 2, which plots the 
slope term for the interaction between ∆miR-195 and ∆Comp when ∆heptanoate was included in the 
regression model. (D) There was a positive interaction between ∆miR-30d and ∆adenosine, a negative 
interaction between ∆adenosine and ∆Comp, and a negative interaction between ∆miR-30d and ∆Comp. 
When ∆adenosine was added to the regression model, the relationship between ∆miR-30d and ∆Comp no 
longer existed; therefore, adenosine significantly mediated the relationship (Sobel p-value = 0.001, Teff = 
60%). The graph depicts the change in slope between model 1, which plots the slope term for the interaction 
between ∆miR-30d and ∆Comp, and model 2, which plots the slope term for the interaction between ∆miR-
30d and ∆Comp when ∆adenosine was included in the regression model. (E) There was a positive 
interaction between ∆miR-30d and ∆adenosine, a negative interaction between ∆adenosine and ∆RT, and a 
negative interaction between ∆miR-30d and ∆RT. When ∆adenosine was added to the regression model, 
the relationship between ∆miR-30d and ∆RT no longer existed; therefore, adenosine significantly mediated 
the relationship (Sobel p-value = 0.001, Teff = 58%). The graph depicts the change in slope between model 
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1, which plots the slope term for the interaction between ∆miR-30d and ∆RT, and model 2, which plots the 
slope term for the interaction between ∆miR-30d and ∆RT when ∆adenosine was included in the regression 
model. (F) There was a negative interaction between ∆miR-151-5p and ∆8-HOA, a positive interaction 
between ∆8-HOA and ∆Comp, and a negative interaction between ∆miR-151-5p and ∆Comp. When ∆8-
HOA was added to the regression model, the relationship between ∆miR-151-5p and ∆Comp no longer 
existed; therefore, 8-HOA significantly mediated the relationship (Sobel p-value = 0.007, Teff = 55%). The 
graph depicts the change in slope between model 1, which plots the slope term for the interaction between ∆miR-151-5p and ∆Comp, and model 2, which plots the slope term for the interaction between ∆miR-1951-
5p and ∆Comp when ∆8-HOA was included in the regression model. (G) There was a negative interaction 
between ∆miR-92a and ∆suberate, a positive interaction between ∆suberate and ∆Comp, and a negative 
interaction between ∆miR-92a and ∆Comp. When ∆suberate was added to the regression model, the 
relationship between ∆miR-92a and ∆Comp no longer existed; therefore, suberate significantly mediated 
the relationship (Sobel p-value = 0.004, Teff = 68%). The graph depicts the change in slope between model 
1, which plots the slope term for the interaction between ∆miR-92a and ∆Comp, and model 2, which plots 
the slope term for the interaction between ∆miR-92a and ∆Comp when ∆suberate was included in the 
regression model. (H) There was a negative interaction between ∆miR-92a and ∆heptanoate, a positive 
interaction between ∆heptanoate and ∆Comp, and a negative interaction between ∆miR-92a and ∆Comp. 
When ∆heptanoate was added to the regression model, the relationship between ∆miR-92a and ∆Comp no 
longer existed; therefore, heptanoate significantly mediated the relationship (Sobel p-value = 0.006, Teff = 
50%). The graph depicts the change in slope between model 1, which plots the slope term for the interaction 
between ∆miR-92a and ∆Comp, and model 2, which plots the slope term for the interaction between ∆miR-
92a and ∆Comp when ∆heptanoate was included in the regression model. 
 
In total, there were 14 significant hypothesized mediations (Sobel p-value < 0.05, Teff > 
50%) comprised of seven metabolites (2-HG, 8-HOA, UND, sebacate, suberate, heptanoate, 
adenosine), six miRNAs (miR-20a, miR-505, miR-92a, miR-151-5p, miR-195, and miR-30d), and 
three VR scores (Comp, Bal, and RT). Of the seven metabolites, six were FAs. Five of the six FAs 
(2-HG, 8-HOA, UND, sebacate, and suberate) significantly increased from pre- to postseason, 
while heptanoate and adenosine, a nucleoside, significantly decreased (Figure 6). Interestingly, 
these five measures - Comp, 8-HOA, miR-505, miR-92a, and miR-151-5p - were observed in both 
pre- and across-season mediations. 
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Figure 6: Box plots of mediation-related metabolites across season. (A) Metabolites associated with 
significant preseason mediations. 2-HG, 8-HOA, and UND significantly increased (q-value < 0.05) from 
pre- to post-season. (B)  Metabolites associated with significant across-season mediations. Sebacate and 
suberate significantly increased (q-value < 0.05) while adenosine and heptanoate decreased from pre- to 
post-season. 
 
Summary of HAE interactions  
Two methods were used to assess HAE interactions: 1) extrapolation of subject-specific 
HAEs to predict preseason VR scores, miRNA levels, and metabolite levels (note: this analysis is 
purely exploratory and should only be considered as setting up hypotheses for future analyses), 2) 
assessment of how HAEs may impact across-season changes in VR scores, miRNA, and 
metabolites.  
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 At preseason, there were six significant interactions between HAEs and miRNAs (5/6 
related to HAEs above 80G) and two interactions between HAEs and metabolites (2/2 related to 
HAEs above 25G) (Table 4). Across-season, there were two significant interactions between HAEs 
and miRNAs (both positive; +𝛽), as well as four interactions between HAEs and metabolites (all 
positive; +𝛽) (Table 4). Interactions with miRNA were related to normalized HAEs (i.e. aHAE25G 
and aHAE80G) while interactions with metabolites (sebacate and suberate) were related to HAEs 
exceeding 25G (cHAE25G and aHAE25G). Significant HAE regressions were plotted in Figure 7 
and their interaction terms with significant across-season mediations can be seen in Figure 2A-I.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Across-season interactions with head acceleration events (HAEs). Four postseason HAE metrics 
(cHAE25G, cHAE80G, aHAE25G, and aHAE80G) were regressed against mediation-related VR scores, miRNA 
levels, and metabolite levels. Cook’s outliers were removed prior to analyses. Results were presented if p-
value < 0.05. Adjusted R2 (R!"#.% ) and standardized beta coefficients (Std. β) were reported for each 
significant regression. 
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Figure 7: HAE-related across-season regression plots. Significant regressions from Supplemental Table 2 
were graphed. Standardized beta coefficients (β; slope), p-values, and correlation coefficients (r) were 
reported for each plot. Relationships between HAEs and miRNA, or metabolite, were all positive (+β). 
 
 
DISCUSSION 
This study tested the hypothesis that contact athletes, who experience repetitive HAEs, 
would exhibit three-way associations between inflammatory-related miRNAs, metabolomic 
compounds, and behaviors implicated by Luria with mTBI [57, 59, 60]. We focused on 
metabolomic measures that were both abnormal across a season of play and (i) FAs and/or 
compounds involved with energy metabolism, (ii) compounds involved with stress/inflammatory 
responses, or (iii) exogenous compounds related to consumption. We expected these three-way 
associations to show statistical mediation which was consistent (i.e., highly specific) in terms of 
the category of independent variable (IV), mediator variable (M), and dependent variable (DV), 
and that computational behavior measures would always be the DV. This hypothesis was 
confirmed with five general findings. First, across-season metabolomic analysis identified 40 
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compounds that were significantly different across-season for three categories of focus [i.e., (i) – 
(iii) above], including a broad array of xanthines that were increased at the end of the season. 
Second, 14 mediation relationships were observed, six with preseason data, and eight with across-
season data. In the all cases, except one, miRNAs were the IVs, metabolomic compounds were the 
mediators, and Comp or Bal behavior were the DVs. There was only one case where miRNA was 
the mediator of these relationships; however, the hypothesis-directed mediation was also 
significant indicating a mixed mediation model. In the majority of cases, biochemical processes 
carried the relationship between inflammatory miRNA and Luria behavior. Third, three of the 
miRNAs showed relationships both preseason and across-season (miR-505, miR-92a, and miR-
151-5p), and 12 of the 14 mediations involved a comprehensive measure of Luria behavior 
(Comp). For one metabolite, 8-HOA, we observed that it significantly mediated miRNA-behavior 
relationships both preseason and across-season. Fourth, all seven of the metabolomic compounds 
mediating relationships between inflammatory miRNA and Luria behavior were those involved 
with some aspect of energy metabolism. Specifically, five of the seven are involved in fatty acid 
oxidation, a sixth compound is involved with diminishing mitochondrial respiration and 
respiration-coupled ATP production in cancer cells (i.e., 2-HG), and a seventh is a core structural 
unit of ATP (i.e., adenosine). It should be noted that altogether, these findings point to a shift 
mitochondria metabolism, away from mitochondria function, consistent with other illnesses 
classified as mitochondrial disorders [84–90].  
 
Metabolite changes indicative of mitochondrial dysfunction and altered metabolism 
Metabolites of the TCA cycle consistently decreased across-season while monohydroxy 
and dicarboxylic FAs increased. This observation points to dysfunctional energy metabolism, 
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specifically related to 𝛽-oxidation. In functional mitochondria, 𝛽-oxidation breaks down FAs into 
acetyl-CoA which is then fed into the TCA cycle for further cellular respiration. However, several 
studies indicate that mitochondria are dysfunctional following mild to severe TBI [29, 31, 32, 35, 
36, 91–94]. Because mitochondria are the predominate site of energy production, their dysfunction 
creates a state of energetic crisis and metabolism thus shifts onto other organelles. Peroxisomes 
are small, dynamic organelles that oxidize FAs using 𝛼-, 𝛽-, and 𝜔-oxidative processes. 𝜔-
oxidation transforms very long, long, medium, and short-chain FAs into dicarboxylic FAs which 
are then 𝛽-oxidized into acetyl-CoA. However, the reported data demonstrate an accumulation of 
medium-chain monohydroxy (7-HOA, 8-HOA) and dicarboxylic (suberate, sebacate, UND) FAs 
and a decrease in TCA metabolites, suggesting that the carboxylic FAs cannot be further oxidized 
into acetyl-CoA for normal TCA cycle respiration (Figure 8). This observation suggests an 
impairment in 𝛽-oxidative processes, a resulting build-up of monohydroxy and dicarboxylic FAs, 
incomplete oxidation of these FAs into acetyl-CoA, and a resulting decrease in TCA-related 
metabolites leading to increased metabolic demand. Intriguingly, increased serum levels of 7-
HOA, 8-HOA, suberate, and sebacate have been observed in patients with medium-chain acyl-
CoA dehydrogenase deficiency (MCADD) – a genetic mitochondrial disorder caused by a 
mutation in the ACADM gene [95–97]. Interestingly, another feature of this disorder is increased 
serum levels of acyl-carnitine derivatives with 6, 8, and 10 carbons. Indeed, these metabolites were 
increased in our cohort; however, most p-values were only trending (p-value > 0.05) and a larger 
cohort must be studied to further validate this observation (Table 5). The last FA observed in 
across-season mediation relationships was heptanoate. Heptanoate is a monohydroxy carboxylic 
fatty acid that decreased across the season of football – opposite of what was observed for the other 
monohydroxy and dicarboxylic fatty acids. Interestingly, increased levels of heptanoate, via 
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metabolism of triheptanoin, has been marked as beneficial in the treatment of 𝛽-oxidation related 
metabolic disorders [98–100]. Therefore, an observed decrease in heptanoate could be detrimental. 
In relation to brain injury, one study observed increased neuronal cell loss with the 
accumulation of free FAs in rat models of TBI [101]. Taken together, the observed increase in 
medium-chain monohydroxy and dicarboxylic FAs, decrease in heptanoate, and concurrent 
decrease in TCA metabolites suggest an impairment in 𝛽-oxidation stemming from injury-induced 
mitochondrial dysfunction, which has been reported in several TBI-related studies [34, 102].  
 
 
Figure 8: Synopsis figure summarizing the observed shift in metabolism and its relationship to 
inflammatory miRNAs and complex behavior. There were significant increases in medium-chain 
monohydroxy and dicarboxylic fatty acids (FAs) (suberate, sebacate, UND, and 8-HOA) from pre- to post-
season. Increases in these FAs have been associated with genetic disorders related to impaired beta-
oxidation. Impairment of this critical process can result in an accumulation of medium-chain FAs which 
cannot be further oxidized into smaller, functional, metabolites, such as acetyl-CoA. Acetyl-CoA is a 
critical starting-point metabolite for the TCA cycle, a major source of energy-rich molecules that are fed 
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into further energy-producing processes (e.g., electron chain transport system). Here, TCA-related 
metabolites (citrate, aconitate, 𝛼-KG, fumarate, and malate) were all observed to decrease, suggesting a 
problem with the initial step of the cycle (i.e. lack of acetyl-CoA). Additionally, there were alterations in 
energy-rich molecules such as adenine, adenosine, nicotinamide, and phosphate, suggesting a state of 
energy imbalance. Lastly, 2-HG, a known oncometabolite, was observed to increase. Regardless of its role 
as an oncometabolite, its increase suggests a state of oxidative stress. Taken together, it is suggested that 
there are dysfunctional beta-oxidative processes in this cohort of collegiate football players leading to 
subsequent issues with energy production.  
 
 
 
Table 5: Changes in acyl-carnitine derivatives. The number of carbons in each metabolite is noted in 
parentheses. Cook’s outliers were removed prior to regression analysis and the number of outliers removed 
in each regression is listed as the ratio of outliers to the total n. p-Values were reported at a significance 
level of 0.05 and a Benjamini-Hochberg FDR correction was applied to obtain q-values and. Negative z-
scores confer an increase from pre- to post-season.  
 
 
Additionally, 2-HG, a known oncometabolite, increased from pre- to postseason. 2-HG is 
dicarboxylic fatty acid generated from 𝛼-ketoglutarate (i.e., oxoglutaric acid), a component of the 
TCA cycle, via the mutated IDH gene [103, 104]. 2-HG can exist in two enantiomeric forms (L 
and D) and both have been implicated in tumor suppressor inactivation and oncogenic activation 
[105–107]. In addition to its oncogenic function, 2-HG is an established marker of oxidative stress 
and has been associated with poorer outcomes following brain injury [108, 109]. Interestingly, L-
2-HG structurally resembles glutamate and thus may affect neurotransmission [110]. Here, an 
increase in 2-HG is likely linked to oxidative stress resulting from repetitive HAEs and may even 
alter neurotransmission and subsequent network connectivity [111–115].  
 In this study, we observed adenosine to be decreased at postseason. Adenosine is a potent 
vasodilator that increases regional cerebral blood flow (rCBF), thereby decreasing energy 
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demands. It is also implicated as a robust neuroprotector and has been reported to suppress ATP 
release [116]. Further, dysregulation of adenosine levels has been reported following TBI and is 
linked with numerous TBI-related pathologies and comorbidities [117]. In particular, severe TBI 
in humans was associated with increased adenosine levels, which was hypothesized to play a 
neuroprotective role and act to uncouple rCBF from oxidative metabolism [118]. In rats, adenosine 
agonists administered 10 minutes post-TBI reduced injury severity following fluid-percussion TBI 
[119]. However, adenosine has also been reported to decrease 24 hours following TBI in rats [116],  
and decreases in extracellular adenosine have been associated with a loss of neuroprotection during 
states of hypoxia and ischemia [120]. These, and other, findings suggest an interplay between 
protective effects of adenosine receptors A1 and A2A, and further research is required to elucidate 
time course effect of adenosine across the full spectrum of TBI. Taken together, our findings 
suggest that exposure to repetitive subconcussive HAEs may trigger a detrimental decrease in 
adenosine and subsequent neuroprotective dysfunction.  
 Another energy-related metabolite, phosphate, was found to increase in the absence of 
mediation relationships. This observation may be associated with reduced ATP synthesis, ATP 
depletion, and/or ATP hydrolysis. In cases of ischemia, mitochondria hydrolyzed ATP more 
frequently [121] and ATP synthesis was impaired in animals of brain injury [122]. Impaired ATP 
synthesis may be related to depleted energy stores and a subsequent lack of energy sources. 
Contrary to these observations, serum phosphate levels were shown to decrease in patients with 
severe TBI [123, 124], yet football athletes experience repetitive subconcussive HAEs. More 
research is required to elucidate the role of phosphate in the full spectrum of TBI.  
Lastly, all xanthine metabolites were increased at postseason suggesting either 1) an 
increase in caffeine consumption [35, 125–128], 2) activation of xanthine oxidases [129–132], or 
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3) a combination of both [29]. Caffeine is an exogenous compound shown to have anti-
inflammatory and neuroprotective effects, especially in the context of neurodegenerative disease 
and TBI [133]. In human studies, caffeine levels were correlated with better outcomes in patients 
with severe TBI [134]; this finding may be related to caffeine-induced neuroprotection via 
blockage of the adenosine receptor, A2A [135, 136]. Additionally, caffeine consumption reduced 
cognitive decline in older women [137], has been suggested to reduce the likelihood of developing 
Alzheimer’s disease [138], and has been linked to improving psychiatric disorder symptoms [139]. 
Moreover, numerous animal studies have demonstrated neuroprotective effects of caffeine 
following TBI [140–142]. However, the timing of caffeine administration may be critical, as was 
seen in a study where caffeine administered prior to TBI was beneficial while caffeine 
administered post-TBI was detrimental [143]. Increased caffeine consumption in this cohort could 
be the result of 1) school-related stress and lack of sleep, 2) compensation for HAE-induced brain 
damage and metabolic dysfunction, or 3) a combination of both. Given the current data, it is not 
possible to identify the exact reason for the increased levels of xanthines and further research is 
required. It should be noted though that previous studies have reported caffeine consumption in 
contact athletes with the main motive being regaining energy lost during exercise [144, 145]. 
 
Metabolite changes mediate the relationship between inflammatory miRNA and Luria behavior 
Previous studies have reported increased levels of inflammatory miRNAs prior to contact 
play and therefore, no changes observed across the season [16, 80]. Additionally, behavioral 
changes alone are rarely observed and difficult to replicate in studies of contact athletes without 
diagnosed concussion [13, 146–149]. However, research points to significant neuroimaging (i.e. 
fMRI, rs-fMRI, DTI, MRS, CVR, rCBF) and biochemical changes in this population across a 
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season of sports participation [3–5, 14, 81, 150–152]; however, behavior is not commonly shown 
to correlate with these changes [3, 13, 149, 153]. Therefore, it was hypothesized that metabolomic 
changes would mediate the relationship between elevated miRNA and potentially subtle changes 
in behavior that could be quantified using virtual reality technology. 
At preseason, there were six significant hypothesis-directed mediations. The metabolites 
mediating the relationship between chronically elevated miRNA and behavior were monohydroxy 
(8-HOA) and dicarboxylic FAs (2-HG and UND). According to the literature, these types of FAs 
were elevated in patients with defective 𝛽-oxidative metabolism [85, 87, 90, 154–156]. The 
accumulation of these specific FAs suggests a state of chronic metabolic dysregulation related to 
ineffective 𝛽-oxidation in mitochondria and peroxisomes. Ultimately, this dysfunction may result 
in an energy crisis as FAs cannot be fully oxidized into acetyl-CoA for normal cellular respiration. 
In fact, decreased levels of acetyl-CoA, as well as increased phosphate and decreased ATP, have 
been observed in rats exposed to repetitive mTBI [29, 32]. The fact that these FAs are mediating 
the miRNA-behavior relationship suggests that dysfunctional 𝛽-oxidation may underlie subtle 
changes in behavior. Moreover, the fact that these relationships were observed prior to contact 
practice and play suggests chronic metabolic dysregulation and neuroinflammation that may 
persist long after season commencement and affect neurological function (Figure 9). 
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Figure 9: Repetitive exposure to subconcussive head impacts (or HAEs) has been shown to produce 
significant changes in brain homeostasis, such as increased neuroinflammation [7, 15, 157–163]. Here, we 
observed changes indicative of mitochondrial distress as evidenced from both the accumulation of medium-
chain FAs and the subsequent decreases in TCA-related metabolites. Mitochondrial dysfunction can lead 
to numerous physiological disturbances, some of which were observed in the present study: 1) oxidative 
stress (i.e., increased levels of 2-HG), 2) impairment in beta-oxidative processes (i.e., increased levels of 
medium-chain FAs), and 3) increased metabolic demands (i.e., decreased TCA and energy-related 
metabolites). Together, these neuroinflammatory processes may be related to the observed elevation in 
inflammatory-related miRNA molecules (specifically miR-20a, miR-505, miR-151-5p, miR-30d, miR-92a, 
and miR-195). In fact, these miRNAs were significantly correlated with the metabolites shown in 3A. In 
addition, the metabolites were shown to mediate the relationship between elevated miRNA levels and 
complex Luria behavior (i.e., computation virtual reality tasks). Together, the mediating effect of these 
energy-related metabolites are critical when defining the relationship between elevated miRNAs and 
behavioral outcomes. This complex relationship may explain why obvious behavioral changes in 
subconcussed athletes have not been routinely observed, but how repetitive, long-term exposure to HAEs, 
chronic elevation of inflammatory-miRNAs, and acute, but deleterious changes in energy metabolites could 
result in behavioral disturbances later in life.  
  
Across-season, there were eight significant hypothesis-directed mediations. Again, the 
majority of mediating metabolites were FAs that were increased across the season and may be 
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related to dysfunctional mitochondrial β-oxidation. However, heptanoate and adenosine were also 
observed in mediation relationships, as discussed in the previous section. The observation of 
significant mediations using change measures across the season indicate that chronically elevated 
miRNAs, as observed in [16], and dynamic metabolic disruption appear to impact neurological 
function. Interestingly, three miRNAs (miR-505, miR-92a, and miR-151-5p) and one metabolite 
(8-HOA) were involved in both pre- and across-season mediations and 12 of the 14 mediations 
involved the comprehensive measure of Luria-based behavior. 
 Together, all seven of the metabolomic compounds mediating relationships between 
inflammatory miRNAs and Luria behavior were involved in some aspect of energy metabolism. 
Additionally, other metabolites that were not observed in mediation relationships, but are involved 
in energy metabolism, were observed to change (e.g., citrate, phosphate; Figure 3A). These 
observations strongly argue for a state of metabolic dysregulation, potentially related to 
dysfunctional mitochondria and subsequent dysfunction in cellular respiration (i.e., TCA cycle and 
downstream energy-producing processes).  
 
HAEs were associated with changes in metabolites and miRNA 
The observed relationships between miRNAs, metabolites, and behavior were related to 
HAE exposures throughout the football season (Table 4). Specifically, across-season measures of 
miRNAs 505 and 92a were significantly related to cumulative and average HAEs exceeding 25G 
and 80G. Additionally, across-season measures of the metabolites sebacate and suberate were 
associated with HAEs exceeding 25G. All across-season relationships were positive, indicating 
that increased HAE exposure was related to larger increases in neuroinflammatory miRNA levels 
and increased metabolomic measures (sebacate and suberate). Preseason results indicate an 
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opposite trend where higher extrapolated HAEs were associated with lower levels of miRNA. This 
is interesting, as it suggests that lower levels of inflammatory-related miRNA may be associated 
with more HAE exposures from the previous season of play. However, these results are purely 
explorative as previous HAEs were not recorded and should only be considered as setting up 
hypotheses for future investigation.  
Previous research, specifically in the neuroimaging field, has demonstrated the role HAEs 
play in neurophysiological changes such as altered connectivity (rs-fMRI and fMRI), 
neurochemical alterations (MRS), altered cerebral blood flow (perfusion imaging), and axonal 
injury (DTI) [4, 7, 168, 13, 15, 80, 151, 164–167]. Here, we present blood biomarkers (metabolites 
and miRNAs) that also correspond to HAE exposure. Interestingly, no behaviors were associated 
with HAEs. This absence of association may be due to inherent limitations of the sensors, a small 
sample size, and/or the fact that competition-related HAEs were not recorded.  
Other limitations of this study include the time course of sample collection and a lack of 
age-matched, non-contact athlete controls.  Blood collections and VR tests were only conducted 
twice – once prior to contact practice and once following the competition season. To observe more 
transient changes in these metrics, it would be beneficial to collect data at more time points during 
and after the season. Additionally, this study lacked age- and gender-matched, non-contact athlete 
controls. Previous reports of miRNA elevations in football athletes utilized healthy, non-age- and 
gender-matched controls [16]. Future studies should incorporate age- and gender-match controls 
that also participate in competitive, non-contact athletics. Lastly, while the sample size was small, 
a rigorous permutation-based statistical approach was applied to account for this limitation while 
controlling for false positives and false negatives.  
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CONCLUSION 
The presented study evaluated the relationships between energy-related metabolites, 
inflammatory-related miRNAs, and Luria-based computational behavior at the preseason and 
across the season. Specifically, metabolites were hypothesized to mediate the relationship between 
elevated miRNAs and VR task performance. The majority of mediation findings involved a fatty 
acid (2-HG, 8-HOA, UND, sebacate, suberate, and heptanoate) and in addition, TCA metabolites 
were found to be significantly decreased at postseason relative to preseason. Lastly, HAEs were 
associated with metabolomic measures and miRNA levels across-season. Together, these 
observations suggest a state of chronic HAE-induced neuroinflammation (as evidence by elevated 
miRNA, [16]) and mitochondrial dysfunction (as observed by altered metabolomic measures) that 
together produce subtle changes in neurological function (as observed by behavioral relationships) 
(Figure 9). Additionally, these complex, multi-scale observations were discovered using an 
integration of permutation-based statistics with mediation analysis; this method may provide a 
technique for other human-focused studies of functional brain illness in lieu of, or in parallel with, 
animal studies. These findings provide preliminary evidence that 14 metabolites, related to 
potential mitochondrial distress, have complex relationships to neuroinflammation and subsequent 
neurological alterations. Therefore, this set of metabolites 1) supports the hypothesis of 
mitochondrial and metabolic dysfunction in subconcussed contact-sport athletes and 2) may serve 
as a promising set of biomarkers for HAE-related neurological change that does not produce 
obvious behavioral deficits. 
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